Sign inJoin waitlistJoin the waitlist

Michelle Rowland

Clinical Assistant Professor · University of Illinois College of Medicine at Peoria

Credentials: · · · · · · · · ·

History

University of Illinois College of Medicine at Peoria
Present

Gynecologic Oncology
UPMC Medical Education
2015–2018
Obstetrics and Gynecology
UPMC Medical Education
2011–2015
University of Illinois College of Medicine
2006–2010

Research

Human risk of infection with Borrelia burgdorferi, the Lyme disease agent, in eastern United States
American Journal of Tropical Medicine and Hygiene · 2012 · 213 citations
Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer
PeerJ · 2021 · 44 citations
Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older
American Journal of Obstetrics and Gynecology · 2015 · First of 5 authors · Corresponding · 29 citations

Kathleen Moore
7 papers
Camille Jackson
5 papers · 4 as a fellow
Aleia Crim
3 papers · 3 as a resident
JG
Jessica Gillen
3 papers · 3 as a resident
MG
Molly Greenwade
3 papers · 3 as a resident
Adam Walter
2 papers · 2 as a fellow
RR
Rachel Ruskin
2 papers · 2 as a fellow
Robert Mannel
2 papers
BK
Bailey Kleis
1 paper
BB
Brian Burnett
1 paper · 1 as a fellow
Courtney Bailey
1 paper · 1 as a fellow
David Shalowitz
1 paper

Clinical trials

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Site PI · Recruiting · Phase 1
Whitehawk Therapeutics, Inc.
2026–2028
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Site PI · Recruiting · Phase 1
Whitehawk Therapeutics, Inc.
2025–2028
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031